NDC 51672-1309-01 - Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1309
- Requested NDC
- 51672-1309-01
- Package NDCs from labels
- 51672-1309-1, 51672-1309-3, 51672-1309-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Betamethasone Dipropionate Gel (Augmented*), 0.05% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1309-1 | Betamethasone Dipropionate | 15 g in 1 TUBE | GEL | 15 | 6 | |
| 51672-1309-1 | Betamethasone Dipropionate | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1309-3 | Betamethasone Dipropionate | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1309-3 | Betamethasone Dipropionate | 50 g in 1 TUBE | GEL | 50 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1309 | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 4 package rows | 20241222_e041ceb2-8bda-4703-b663-804e7b462e32.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1309-1 | GM - Gram | 51672-1309 | 8f10039b-85a5-4ecd-bcea-3bab503cd157 | 1 | 2012-07-24 |
| 51672-1309-3 | GM - Gram | 51672-1309 | aaa573ed-58dc-4041-9cbf-2a97c4d5b376 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Betamethasone Dipropionate | ACTIVE INGREDIENT | 826Y60901U | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Betamethasone | ACTIVE MOIETY | 9842X06Q6M | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane COMPLETE | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 2df0de02-a3e2-471a-9e10-040c3fba75fe | 2025-08-08 | Warnings | 6DC9Q167V3 |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | f2c557ea-275b-4ab4-90f4-4003e022214d | 2025-08-07 | Warnings, Adverse reactions | 826Y60901U |
| Systane Balance | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | c7b1a03a-a5f2-409e-a34a-d6f166671de5 | 2025-08-07 | Warnings | 6DC9Q167V3 |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | 52c0e92f-986e-45e7-99cf-9a13ac386b1d | 2025-07-28 | Adverse reactions | 826Y60901U |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Golden State Medical Supply, Inc. | 9571a031-179d-7dfb-e053-2995a90aa016 | 2025-07-10 | Adverse reactions | 826Y60901U |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | e4e9f244-4a85-4c0d-9917-93182c4a6e87 | 2025-07-07 | Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 3b23a3c0-3306-4a2d-932d-25916d16dc68 | 2025-07-07 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | dc3dd2f7-38ad-4c4c-8602-29b33cc6af90 | 2025-07-07 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | bc12c828-54ba-411d-b752-9b735f7adf63 | 2025-07-02 | Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | e041ceb2-8bda-4703-b663-804e7b462e32 | 2025-07-02 | Adverse reactions | ANDA076508 51672-1309-3 51672-1309-1 51672-1309 51672130901 848208 38f65f63-5416-f33d-e063-6294a90a4238 e041ceb2-8bda-4703-b663-804e7b462e32 826Y60901U |
| Calcipotriene and Betamethasone Dipropionate | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191 | 2025-07-01 | Warnings, Adverse reactions | 826Y60901U |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 75862805-2cfc-fb45-e053-2991aa0a1403 | 2025-04-03 | Warnings, Adverse reactions | 826Y60901U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.